FutureChem Non-registered Executive Park Yeong-ja Plans OTC Sale of Shares and Rights to Fund Rights Offering Subscription - Expected Slight Ownership Decrease


  • FutureChem non-registered executive and de facto controlling shareholder Park Yeong-ja plans to sell 92,532 common shares and 140,924 subscription rights over-the-counter from July 22 to August 20, 2026.
  • The sale aims to raise funds for participation in the company's rights offering and general public offering after forfeited shares, with an estimated total transaction amount of approximately 2.66 billion KRW.
  • After the sale, Park's common share ownership is expected to decrease from 5.94% to 5.53%, and her rights holdings will also reduce.
  • Since the transaction is OTC, actual sale prices may vary; the value of the subscription rights depends on theoretical price and discount rate.
  • [AI Summary]FutureChem major shareholder's partial stake sale to fund rights offering participation suggests an attempt to defend against dilution, but the OTC nature and potential discount may negatively impact short-term stock price.

KOSDAQ Filing Information


  • Report On Transaction Plan Of Specific Securities By Executives And Major Shareholders
  • Company: FutureChem (220100)
  • Submission: Park Yeong-ja

  • Shares: 22,427,420
  • Price: 11,190 KRW
  • Market Cap: 251 B KRW